global Recombinant DNA Technology market size is expected to be worth around US$ 944.6 billion by 2030, according to a new report by Vision Research Reports.
The global Recombinant DNA Technology market size was valued at US$ 597.7 billion in 2020.
Growth Factors
The success of genetically engineered human insulin in diabetes treatment has triggered the development of many other recombinant therapeutics and drugs. This has translated to the huge success of Recombinant DNA (rDNA) technology. This technology has offered significant prospects for elucidating the gap between disease and its effective treatment.
Widespread successful application of this technique in veterinary product development, genetically modified crop development, biopesticides & biofuel production, and gene therapy, are expected to spur the adoption of this technology throughout the forecast period.
The use of Genetically Modified (GM) products, such as GM animals, developed using the rDNA method are found to be indispensable to accelerate medical research. Furthermore, more than 3000 scientific studies have been carried out to assess GM product safety in context to its impact on human health and the environment.
In addition, there is a rising need to improve the recombinant proteins’ production capacity by several folds, owing to an increase in demand for effective therapeutics for disease treatment. The aforementioned fact pronounces the technological advances in this sector thus driving growth.
As per Monsanto and other proponents of GM crops, genetic engineering is one of the fastest and widely adopted agricultural innovations over the past few years. This, in turn, is expected to bolster the adoption of rDNA technology for non-traditional applications.
Report Highlights
rDNA technology has revolutionized the medical field and is having an ever-increasing impact on clinical medicine. It has facilitated disease treatment by insertion of new genes in place of damaged & diseased genes. The medical segment is further bifurcated into the therapeutic agents, recombinant protein, and . Out of all, therapeutic agents captured dominance over its counterpart segments owing to the presence of a substantial number of genetically engineered products for clinical applications.
However, vaccines are expected to be a source of lucrative revenue generation in the coming years due to the presence of a robust vaccine pipeline. Advancements in genetic engineering and process development are anticipated to drive growth in this segment. The non-medical segment of this market is majorly driven by the success of GM crops.
Global hectarage of biotech crops is observed to rise from 110-fold from 1.7 million hectares (1996) to 185.1 million hectares (2016). The top 5 countries that are engaged in planting biotech crops by hectarage are the USA, Brazil, Argentina, Canada, and India. Major GM crops are soybean, maize, cotton, and canola. The rise in the penetration of associated technologies such as genome editing in plant tissue engineering is expected to usher progress in this segment.
The expression system and cloning vector are recognized as the two key elements of this technology. Expression systems captured the largest share owing to the ongoing developments for efficient protein expression and for its further isolation on a large scale. Majorly used expression systems are mammalian, bacterial, insects, and yeast. The development of cell lines such as HEK293 and Chinese Hamster Ovarian (CHO) has contributed to the significant share of mammalian expression systems.
In addition, ongoing research studies to explore the potential of plant as expression system are expected to drive the adoption of plan expression systems for GM product development in the coming years. Cloning vectors are recognized as the backbone for the production of DNA inserts.
Rapid advances in genetic engineering have played a major role in reshaping the usage of these techniques in health & disease, agriculture, and the environment. Health & disease application has accounted for the large share and is expected to maintain its dominance throughout the forecast period. This large share can be attributed to the presence of a wide range of recombinant products for human disease treatment such as drugs, vaccines, and enzymes replacements. Moreover, the extended use of this technology for animal disease treatment has also driven the progress of this segment.
With the growing burden of crop improvement and consequent stress on farmers to meet the customer’s need, this technology has gradually evolved as a panacea for addressing these issues of the agriculture sector. This, in turn, has resulted in a notable success of the recombination techniques in food and agriculture application. Other applications, such as biofuel production, are expected to witness considerable growth in the coming years. This is mainly due to ongoing research activities to augment the scope of the space.
Various end-use segments served by this recombinant DNA technology market include pharmaceutical & biotech entities, academic & research institutes, and other industrial entities. Pharmaceutical & biotech firms are major beneficiaries in this market as the techniques accelerate their drug development capabilities. Moreover, the end-products using rDNA techniques in this segment are highly valued and observed to have significant improvement in productivity. Hence, these organizations account for a larger share.
Moreover, significant capital expenditure taken up by the companies for the development of a wide range of recombinant human therapeutics is supportive of the estimated share. These organizations are anticipated to maintain dominance in the coming years as a consequence of rising adoption for biologics production.
The largest share of the North America region can be attributed to the fact that a substantial number of biopharmaceutical manufacturing participants are headquartered in the U.S. Moreover, the presence of effective regulatory bodies to monitor the various ethical and scientific concerns pertaining to the use of technology have driven the regional growth. In July 2017, this country witnessed the 1st FDA approval for U.S. gene therapy treatment. The treatment was developed for leukemia, as a result of a collaboration between the University of Pennsylvania and Novartis Corp. This, in turn, is anticipated to nurture the implementation of rDNA techniques in the region.
The presence of low-cost manufacturing centers in the Asian economies, such as China, has driven significant attention from global entities to translocate their business in this region. Furthermore, Japan is recognized as one of the world’s largest per capita importers of food and feed developed using modern biotechnology tools. Japan’s regulatory system for GE crops continues to improve. Moreover, there is no significant trade barrier in Japan to hamper GE products export from western countries. As a result, Asia Pacific is expected to emerge as the fastest-growing regional market.
Key Players
F. Hoffmann-La Roche Ltd (Genentech, Inc); Profacgen; Amgen Inc; Novartis AG; GenScript; Pfizer Inc; Novo Nordisk A/S; Eli Lilly and Company; Sanofi; Merck & Co., Inc.; Biogen; Biocon; GlaxoSmithKline plc; New England Biolabs.; Cibus; Monsanto Company, and Horizon Discovery Group PLC.
Market Segmentation
Product Outlook
Medical
Therapeutic Agent
Human Protein
Vaccine
Non-medical
Biotech Crops
Specialty Chemicals
Others
Component Outlook
Expression System
Mammalian
Bacteria
Yeast
Baculovirus / insect
Others
Cloning Vector
Application Outlook
Food & Agriculture
Health & Disease
Human
Animal
Environment
Others
End-use Outlook
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Regional Outlook
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
China
Japan
Latin America
Brazil
Middle East & Africa
South Africa
The Recombinant DNA Technology market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Recombinant DNA Technology market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Recombinant DNA Technology market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant DNA Technology market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Recombinant DNA Technology market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Recombinant DNA Technology capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Recombinant DNA Technology by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Recombinant DNA Technology market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Recombinant DNA Technology market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Recombinant DNA Technology market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Recombinant DNA Technology industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Recombinant DNA Technology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Recombinant DNA Technology market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Recombinant DNA Technology market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Recombinant DNA Technology market. These factors have benefited the growth of the global market for Recombinant DNA Technology. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Recombinant DNA Technology. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Recombinant DNA Technology are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers